Alimera Sciences (NASDAQ:ALIM) reported quarterly sales of $14.535 million which beat the analyst consensus estimate of $13.760 million by 5.63 percent. This is a 12.76 percent increase over sales of $12.890 million the
Benzinga · 04/29 20:02
Alimera Sciences Announces First Quarter 2020 Financial Results and Provides Corporate Update
First Quarter and Recent Company Highlights: Consolidated Net Revenue Up 12% Compared to First Quarter 2019International Net Revenue Up 23% Compared to First Quarter 2019Net.
GlobeNewswire · 04/29 20:00
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 28.)